Characteristic | Number (%) |
---|---|
Number of cases 196 | |
Age (median) | 56 (range 27-91) |
Positive lymph nodes (median) | 4 (range 0-45) |
Histological grade | |
Grade I (well differentiated) | 7 (3.7%) |
Grade II (moderately differentiated) | 36 (19.1%) |
Grade III (poorly differentiated) | 145 (77.1%) |
Stage | |
Stage IIA | 58 (29.7%) |
Stage IIB | 75 (38.5%) |
Stage IIIA | 23 (11.8%) |
Stage IIIB | 26 (13.3%) |
Stage IIIC | 4 (2.1%) |
Stage IV | 9 (4.6%) |
Estrogen receptor (ER) | |
Positive | 155 (79.9%) |
Negative | 39 (20.1%) |
Progesterone receptor (PR) | |
Positive | 112 (57.7%) |
Negative | 82 (42.3%) |
HER-2 | |
Positive | 41 (21.2%) |
Negative | 152 (78.8%) |
Triple Negative status | |
No | 168 (87.5%) |
Yes | 24 (12.5%) |
Lymphovascular invasion (LVI) | |
No | 91 (49.5%) |
Yes | 93 (50.5%) |